Skip to content
Riskpilot
← Back to search
Sign in
Get full access
GENMAB A/S
A/S
Active
CVR 21023884
Carl Jacobsens Vej 30, 2500
Valby
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 1998 · 28 years old
681 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
GENMAB A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
6B
13B
19B
25B
8.5B
2021
14.8B
2022
17.1B
2023
22.2B
2024
3.7B
2025
EBITDA
DKK millions
11660M
8745M
5830M
2915M
0M
3256M
2021
5822M
+79%
2022
5693M
-2%
2023
9328M
+64%
2024
1352M
-86%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
8.509.000
14.827.000
17.126.000
22.167.000
3.659.000
Staff expenses
-1.296.000
-2.728.000
-2.521.000
-0
—
EBITDA
3.256.000
5.822.000
5.693.000
9.328.000
1.352.000
Depreciation & amort.
-0
-0
-0
-0
—
EBIT
3.256.000
5.822.000
5.693.000
9.328.000
1.352.000
Net financials
727.000
931.000
328.000
5.165.000
163.000
Profit before tax
3.983.000
9.753.000
6.021.000
14.493.000
1.515.000
Tax
975.000
1.511.000
1.277.000
2.626.000
311.000
Net profit
3.008.000
5.242.000
4.744.000
11.867.000
1.204.000
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
24.328.000
30.838.000
37.325.000
47.069.000
13.379.000
Equity
22.196.000
28.275.000
32.874.000
41.596.000
6.720.000
Long-term debt
487.000
480.000
727.000
3.094.000
5.467.000
Short-term debt
1.639.000
2.083.000
3.724.000
2.379.000
1.192.000
Total debt
2.132.000
2.563.000
4.451.000
5.473.000
6.659.000
Financial ratios
5-year trend
EBITDA margin
36.9%
This company
15.8%
Market median
+134% vs market
2021
2025
Equity ratio
50.2%
This company
38.2%
Market median
+31% vs market
2021
2025
Return on equity
17.9%
This company
18.4%
Market median
+3% vs market
2021
2025
Net profit margin
32.9%
This company
8.1%
Market median
+306% vs market
2021
2025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
2021
2025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on GENMAB A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
